Association of Long-Term HbA1c Variability with Anxiety and Depression in Patients with Type 2 Diabetes: A Cross-Sectional Retrospective Study

References

• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326(24):2498–2506. doi:10.1001/jama.2021.22208
   PubMed Web of Science ®Google Scholar
• Woon LSC, Sidi HB, Ravindran A, et al. Depression, anxiety, and associated factors in patients with diabetes: evidence from the anxiety, depression, and personality traits in diabetes mellitus (ADAPT-DM) study. BMC Psychiatry. 2020;20(1):227. doi:10.1186/s12888-020-02615-y
   PubMed Web of Science ®Google Scholar
• Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010;87(3):302–312. doi:10.1016/j.diabres.2010.01.024
   PubMed Web of Science ®Google Scholar
• Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther. 2018;20(S2):S25–S215. doi:10.1089/dia.2018.0092
   PubMedGoogle Scholar
• de Ornelas Maia AC, de Azevedo Braga A, Brouwers A, Nardi AE, e Silva AC. Prevalence of psychiatric disorders in patients with diabetes types 1 and 2. Compr Psychiatry. 2012;53(8):1169–1173. doi:10.1016/j.comppsych.2012.03.011
   PubMed Web of Science ®Google Scholar
• Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi JT, Siafarikas A. Symptoms of depression and anxiety in youth with type 1 diabetes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2016;70:70–84. doi:10.1016/j.psyneuen.2016.04.019
   PubMed Web of Science ®Google Scholar
• Egede LE, Dismuke CE. Serious psychological distress and diabetes: a review of the literature. Curr Psychiatry Rep. 2012;14(1):15–22. doi:10.1007/s11920-011-0240-0
   PubMed Web of Science ®Google Scholar
• Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the diabetes control and complications trial. Diabetes Care. 2008;31(11):2198–2202. doi:10.2337/dc08-0864
   PubMed Web of Science ®Google Scholar
• Šoupal J, Škrha J, Fajmon M, et al. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control. Diabetes Technol Ther. 2014;16(4):198–203. doi:10.1089/dia.2013.0205
   PubMed Web of Science ®Google Scholar
• Hamer M, Batty GD, Kivimaki M. Haemoglobin A1c, fasting glucose and future risk of elevated depressive symptoms over 2 years of follow-up in the English longitudinal study of ageing. Psychol Med. 2011;41(9):1889–1896. doi:10.1017/S0033291711000079
   PubMed Web of Science ®Google Scholar
• Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934–942. doi:10.2337/diacare.23.7.934
   PubMed Web of Science ®Google Scholar
• Yang W, Liu M, Tian Y, et al. The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality. BMC Endocr Disord. 2022;22(1):232. doi:10.1186/s12902-022-01147-8
   PubMed Web of Science ®Google Scholar
• Mansori K, Shiravand N, Shadmani FK, et al. Association between depression with glycemic control and its complications in type 2 diabetes. Diabetes Metab Syndr. 2019;13(2):1555–1560. doi:10.1016/j.dsx.2019.02.010
   PubMed Web of Science ®Google Scholar
• Bazelmans E, Netea-Maier RT, Vercoulen JH, Tack CJ. Surprisingly few psychological problems and diabetes-related distress in patients with poor glycaemic control. Neth J Med. 2016;74(1):16–21.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):S62–69. doi:10.2337/dc11-S062
   PubMed Web of Science ®Google Scholar
• Nouwen A, Deschênes SS, Balkhiyarova Z, Albertorio-Díaz JR, Prokopenko I, Schmitz N. Measurement invariance testing of the patient health questionnaire-9 (PHQ-9) across people with and without diabetes mellitus from the NHANES, EMHS and UK Biobank datasets. J Affect Disord. 2021;292:311–318. doi:10.1016/j.jad.2021.05.031
   PubMed Web of Science ®Google Scholar
• Toussaint A, Hüsing P, Gumz A, et al. Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7). J Affect Disord. 2020;265:395–401. doi:10.1016/j.jad.2020.01.032
   PubMed Web of Science ®Google Scholar
• Forbes A, Murrells T, Mulnier H, Sinclair AJ. Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(6):476–486. doi:10.1016/S2213-8587(18)30048-2
   PubMed Web of Science ®Google Scholar
• Li S, Nemeth I, Donnelly L, Hapca S, Zhou K, Pearson ER. Visit-to-Visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2020;43(2):426–432. doi:10.2337/dc19-0823
   PubMed Web of Science ®Google Scholar
• Stein DJ, Scott KM, de Jonge P, Kessler RC. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 2017;19(2):127–136. doi:10.31887/DCNS.2017.19.2/dstein
   PubMed Web of Science ®Google Scholar
• Smith KJ, Béland M, Clyde M, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99. doi:10.1016/j.jpsychores.2012.11.013
   PubMed Web of Science ®Google Scholar
• Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest. 1985;87(1):35–38. doi:10.1378/chest.87.1.35
   PubMed Web of Science ®Google Scholar
• Chaturvedi SK, Manche Gowda S, Ahmed HU, et al. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus. Gen Psychiatr. 2019;32(4):e100076. doi:10.1136/gpsych-2019-100076
   PubMed Web of Science ®Google Scholar
• Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev. 2011;31(8):1239–1246. doi:10.1016/j.cpr.2011.08.001
   PubMed Web of Science ®Google Scholar
• Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002;53(6):1053–1060. doi:10.1016/s0022-3999(02)00417-8
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–1078. doi:10.2337/diacare.24.6.1069
   PubMed Web of Science ®Google Scholar
• Choi KW, Kim YK, Jeon HJ. Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment. Adv Exp Med Biol. 2020;1191:219–235. doi:10.1007/978-981-32-9705-0_14
   PubMed Web of Science ®Google Scholar
• Tiller JWG. Depression and anxiety. Med J Aust. 2013;199(S6):S28–31. doi:10.5694/mja12.10628
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Mersha AG, Tollosa DN, Bagade T, Eftekhari P. A bidirectional relationship between diabetes mellitus and anxiety: a systematic review and meta-analysis. J Psychosom Res. 2022;162:110991. doi:10.1016/j.jpsychores.2022.110991
   PubMed Web of Science ®Google Scholar
• Sun N, Lou P, Shang Y, et al. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open. 2016;6(8):e012540. doi:10.1136/bmjopen-2016-012540
   PubMed Web of Science ®Google Scholar
• Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153–161. doi:10.1111/j.1464-5491.2008.02648.x
   PubMed Web of Science ®Google Scholar
• Gonzalez Heredia T, González-Ramírez LP, Hernández-Corona DM, Maciel-Hernández EA. Anxious depression in patients with Type 2 Diabetes Mellitus and its relationship with medication adherence and glycemic control. Glob Public Health. 2021;16(3):460–468. doi:10.1080/17441692.2020.1810735
   PubMed Web of Science ®Google Scholar
• Déniz-García A, Díaz-Artiles A, Saavedra P, Alvarado-Martel D, Wägner AM, Boronat M. Impact of anxiety, depression and disease-related distress on long-term glycaemic variability among subjects with Type 1 diabetes mellitus. BMC Endocr Disord. 2022;22(1):122. doi:10.1186/s12902-022-01013-7
   PubMed Web of Science ®Google Scholar
• Ravona-Springer R, Heymann A, Schmeidler J, et al. Hemoglobin A1c variability predicts symptoms of depression in elderly individuals with type 2 diabetes. Diabetes Care. 2017;40(9):1187–1193. doi:10.2337/dc16-2754
   PubMed Web of Science ®Google Scholar
• Klimontov VV, Saik OV, Korbut AI. Glucose Variability: how Does It Work? Int J Mol Sci. 2021;22(15):7783. doi:10.3390/ijms22157783
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim OY, Song J. Alleviation of depression by glucagon-like peptide 1 through the regulation of neuroinflammation, neurotransmitters, neurogenesis, and synaptic function. Front Pharmacol. 2020;11:1270. doi:10.3389/fphar.2020.01270
   PubMed Web of Science ®Google Scholar
• Huang H, Liu Q, Zhu L, et al. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284. doi:10.1038/s41598-019-39150-0
   PubMed Web of Science ®Google Scholar
• Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600. doi:10.1016/j.bbi.2020.07.037
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou D, Dai Z, Li X. Association between systemic immune-inflammation index and diabetic depression. Clin Interv Aging. 2021;16:97–105. doi:10.2147/CIA.S285000
   PubMed Web of Science ®Google Scholar
• Zhang C, Bi Y, Jin G, Gan H, Yu L. High and fluctuating glucose levels increase the expression and secretion of interleukin‑18 in mouse peritoneal macrophages. Mol Med Rep. 2015;12(2):2715–2720. doi:10.3892/mmr.2015.3753
   PubMed Web of Science ®Google Scholar
• Li-Bo Y, Wen-Bo Q, Xiao-Hong L, You-Lun F, Tie Z. Intermittent high glucose promotes expression of proinflammatory cytokines in monocytes. Inflamm Res. 2011;60(4):367–370. doi:10.1007/s00011-010-0279-0
   PubMed Web of Science ®Google Scholar
• Smith KJ, Au B, Ollis L, Schmitz N. The association between C-reactive protein, Interleukin-6 and depression among older adults in the community: a systematic review and meta-analysis. Exp Gerontol. 2018;102:109–132. doi:10.1016/j.exger.2017.12.005
   PubMed Web of Science ®Google Scholar
• Hestad KA, Engedal K, Whist JE, et al. Patients with depression display cytokine levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis. Neuropsychiatr Dis Treat. 2016;12:817–822. doi:10.2147/NDT.S101925
   PubMed Web of Science ®Google Scholar
• Carvalho LA, Torre JP, Papadopoulos AS, et al. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J Affect Disord. 2013;148(1):136–140. doi:10.1016/j.jad.2012.10.036
   PubMed Web of Science ®Google Scholar
• Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018;30(1):1–16. doi:10.1017/neu.2016.69
   PubMed Web of Science ®Google Scholar
• Felger JC, Treadway MT. Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology. 2017;42(1):216–241. doi:10.1038/npp.2016.143
   PubMed Web of Science ®Google Scholar
• Trento M, Trevisan M, Raballo M, et al. Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest. 2014;37(1):79–85. doi:10.1007/s40618-013-0028-7
   PubMed Web of Science ®Google Scholar
• Stute P, Lozza-Fiacco S. Strategies to cope with stress and anxiety during the menopausal transition. Maturitas. 2022;166:1–13. doi:10.1016/j.maturitas.2022.07.015
   PubMed Web of Science ®Google Scholar
• Sympa P, Vlachou E, Kazakos K, Govina O, Stamatiou G, Lavdaniti M. Depression and self-efficacy in patients with type 2 diabetes in northern Greece. Endocr Metab Immune Disord Drug Targets. 2018;18(4):371–378. doi:10.2174/1871530317666171120154002
   PubMed Web of Science ®Google Scholar
• Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry. 2010;196(6):440–446. doi:10.1192/bjp.bp.109.065912
   PubMed Web of Science ®Google Scholar
• Harshfield EL, Pennells L, Schwartz JE, et al. Association between depressive symptoms and incident cardiovascular diseases. JAMA. 2020;324(23):2396–2405. doi:10.1001/jama.2020.23068
   PubMed Web of Science ®Google Scholar
• Swardfager W, MacIntosh BJ. Depression, type 2 diabetes, and poststroke cognitive impairment. Neurorehabil Neural Repair. 2017;31(1):48–55. doi:10.1177/1545968316656054
   PubMed Web of Science ®Google Scholar
• Scott KM. Depression, anxiety and incident cardiometabolic diseases. Curr Opin Psychiatry. 2014;27(4):289–293. doi:10.1097/YCO.0000000000000067
   PubMed Web of Science ®Google Scholar
• Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med. 2003;65(3):376–383. doi:10.1097/01.psy.0000041624.96580.1f
   PubMed Web of Science ®Google Scholar
• Lam YY, Tsai SF, Chen PC, Kuo YM, Chen YW. Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice. Biomed Pharmacother. 2021;140:111734. doi:10.1016/j.biopha.2021.111734
   PubMed Web of Science ®Google Scholar
• Loas G, Dalleau E, Lecointe H, Yon V. Relationships between anhedonia, alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive protein and serum lipid levels among 122 inpatients with mood or anxious disorders. Psychiatry Res. 2016;246:296–302. doi:10.1016/j.psychres.2016.09.056
   PubMed Web of Science ®Google Scholar
• Cavicchioli FL, Maes M, Roomruangwong C, et al. Associations between severity of anxiety and clinical and biological features of major affective disorders. Psychiatry Res. 2018;260:17–23. doi:10.1016/j.psychres.2017.11.024
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang C, Chen L, et al. A cross-sectional study to investigate the correlation between depression comorbid with anxiety and serum lipid levels. Compr Psychiatry. 2016;69:163–168. doi:10.1016/j.comppsych.2016.05.005
   PubMed Web of Science ®Google Scholar
• De Berardis D, Serroni N, Campanella D, et al. Alexithymia, suicide ideation, C-reactive protein, and serum lipid levels among outpatients with generalized anxiety disorder. Arch Suicide Res. 2017;21(1):100–112. doi:10.1080/13811118.2015.1004485
   PubMed Web of Science ®Google Scholar